Search research articles
Contact Us
Filters
Showing results (11-20 of 68) with videos related to
Page
of 7
Sort By:
Journal of the American College of Cardiology
|
February 18, 2022
Reply: Reduction in Risk of Disease Progression With Triple Therapy: Is it True for All?
Kelly M Chin, Martin Doelberg, Nicolas Martin, et al.
Chest
|
July 25, 2007
Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels
Kelly M Chin, Richard N Channick, Nick H Kim, et al.
Journal of Thoracic Disease
|
April 12, 2021
Parenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction
Colin A Hinkamp, Trushil Shah, Sonja Bartolome, et al.
Pulmonary Circulation
|
June 4, 2020
Pulmonary Arterial Hypertension-Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting
Robert P Frantz, Kelly M Chin, Carol Zhao, et al.
Chest
|
April 22, 2018
Mortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids
Sonja D Bartolome, Namita Sood, Trushil G Shah, et al.
Circulation. Heart Failure
|
July 18, 2015
Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis
Ambarish Pandey, Sushil Garg, Monica Khunger, et al.
The International Journal of Cardiovascular Imaging
|
April 15, 2016
Right atrial emptying fraction non-invasively predicts mortality in pulmonary hypertension
Konstadina Darsaklis, Matthew E Dickson, William Cornwell, et al.
Pulmonary Circulation
|
April 17, 2023
Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy
Muhammad Abu-Rmaileh, Omer Mirza, Chandni Patel, et al.
The American Journal of Cardiology
|
May 21, 2008
Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension
Kelly M Chin, Martha Kingman, James A de Lemos, et al.
Chest
|
August 23, 2008
Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension
Kelly M Chin, Richard N Channick, James A de Lemos, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 68) with videos related to
Sort By:
Page
of 7
Journal of the American College of Cardiology
|
February 18, 2022
Reply: Reduction in Risk of Disease Progression With Triple Therapy: Is it True for All?
Kelly M Chin, Martin Doelberg, Nicolas Martin, et al.
Chest
|
July 25, 2007
Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels
Kelly M Chin, Richard N Channick, Nick H Kim, et al.
Journal of Thoracic Disease
|
April 12, 2021
Parenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction
Colin A Hinkamp, Trushil Shah, Sonja Bartolome, et al.
Pulmonary Circulation
|
June 4, 2020
Pulmonary Arterial Hypertension-Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting
Robert P Frantz, Kelly M Chin, Carol Zhao, et al.
Chest
|
April 22, 2018
Mortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids
Sonja D Bartolome, Namita Sood, Trushil G Shah, et al.
Circulation. Heart Failure
|
July 18, 2015
Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis
Ambarish Pandey, Sushil Garg, Monica Khunger, et al.
The International Journal of Cardiovascular Imaging
|
April 15, 2016
Right atrial emptying fraction non-invasively predicts mortality in pulmonary hypertension
Konstadina Darsaklis, Matthew E Dickson, William Cornwell, et al.
Pulmonary Circulation
|
April 17, 2023
Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy
Muhammad Abu-Rmaileh, Omer Mirza, Chandni Patel, et al.
The American Journal of Cardiology
|
May 21, 2008
Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension
Kelly M Chin, Martha Kingman, James A de Lemos, et al.
Chest
|
August 23, 2008
Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension
Kelly M Chin, Richard N Channick, James A de Lemos, et al.
Page
of 7